These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

886 related items for PubMed ID: 12037567

  • 1. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T, Li S, Strittmatter SM.
    Nature; 2002 May 30; 417(6888):547-51. PubMed ID: 12037567
    [Abstract] [Full Text] [Related]

  • 2. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
    Li S, Strittmatter SM.
    J Neurosci; 2003 May 15; 23(10):4219-27. PubMed ID: 12764110
    [Abstract] [Full Text] [Related]

  • 3. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat.
    Cao Y, Shumsky JS, Sabol MA, Kushner RA, Strittmatter S, Hamers FP, Lee DH, Rabacchi SA, Murray M.
    Neurorehabil Neural Repair; 2008 May 15; 22(3):262-78. PubMed ID: 18056009
    [Abstract] [Full Text] [Related]

  • 4. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE, Liu BP, Park JH, Strittmatter SM.
    Neuron; 2004 Oct 28; 44(3):439-51. PubMed ID: 15504325
    [Abstract] [Full Text] [Related]

  • 5. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
    Yu P, Huang L, Zou J, Yu Z, Wang Y, Wang X, Xu L, Liu X, Xu XM, Lu PH.
    Neurobiol Dis; 2008 Dec 28; 32(3):535-42. PubMed ID: 18930141
    [Abstract] [Full Text] [Related]

  • 6. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin.
    Fournier AE, Gould GC, Liu BP, Strittmatter SM.
    J Neurosci; 2002 Oct 15; 22(20):8876-83. PubMed ID: 12388594
    [Abstract] [Full Text] [Related]

  • 7. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor.
    Liu BP, Fournier A, GrandPré T, Strittmatter SM.
    Science; 2002 Aug 16; 297(5584):1190-3. PubMed ID: 12089450
    [Abstract] [Full Text] [Related]

  • 8. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
    Li S, Liu BP, Budel S, Li M, Ji B, Walus L, Li W, Jirik A, Rabacchi S, Choi E, Worley D, Sah DW, Pepinsky B, Lee D, Relton J, Strittmatter SM.
    J Neurosci; 2004 Nov 17; 24(46):10511-20. PubMed ID: 15548666
    [Abstract] [Full Text] [Related]

  • 9. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
    Guo X, Zahir T, Mothe A, Shoichet MS, Morshead CM, Katayama Y, Tator CH.
    Cell Transplant; 2012 Nov 17; 21(6):1177-97. PubMed ID: 22236767
    [Abstract] [Full Text] [Related]

  • 10. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q, Cai W, Li S, Zhang Y, Su B.
    Brain Res Bull; 2013 Oct 17; 99():140-4. PubMed ID: 24184005
    [Abstract] [Full Text] [Related]

  • 11. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.
    Ji B, Li M, Budel S, Pepinsky RB, Walus L, Engber TM, Strittmatter SM, Relton JK.
    Eur J Neurosci; 2005 Aug 17; 22(3):587-94. PubMed ID: 16101740
    [Abstract] [Full Text] [Related]

  • 12. Why do Nogo/Nogo-66 receptor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents?
    Teng FY, Tang BL.
    J Neurochem; 2005 Aug 17; 94(4):865-74. PubMed ID: 16092935
    [Abstract] [Full Text] [Related]

  • 13. Neuroscience. It takes more than two to Nogo.
    Woolf CJ, Bloechlinger S.
    Science; 2002 Aug 16; 297(5584):1132-4. PubMed ID: 12183616
    [No Abstract] [Full Text] [Related]

  • 14. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Zheng B, Atwal J, Ho C, Case L, He XL, Garcia KC, Steward O, Tessier-Lavigne M.
    Proc Natl Acad Sci U S A; 2005 Jan 25; 102(4):1205-10. PubMed ID: 15647357
    [Abstract] [Full Text] [Related]

  • 15. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth.
    Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, Kimura N, Cai H, Deng K, Gao Y, He Z, Filbin M.
    Neuron; 2002 Jul 18; 35(2):283-90. PubMed ID: 12160746
    [Abstract] [Full Text] [Related]

  • 16. Antibodies neutralizing Nogo-A increase pan-cadherin expression and motor recovery following spinal cord injury in rats.
    Atalay B, Bavbek M, Cekinmez M, Ozen O, Nacar A, Karabay G, Gulsen S.
    Spinal Cord; 2007 Dec 18; 45(12):780-6. PubMed ID: 17724451
    [Abstract] [Full Text] [Related]

  • 17. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice.
    Steward O, Sharp K, Yee KM, Hofstadter M.
    Exp Neurol; 2008 Feb 18; 209(2):446-68. PubMed ID: 18234196
    [Abstract] [Full Text] [Related]

  • 18. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
    Wang YT, Lu XM, Zhu F, Huang P, Yu Y, Zeng L, Long ZY, Wu YM.
    Biomaterials; 2011 Nov 18; 32(31):7988-98. PubMed ID: 21784510
    [Abstract] [Full Text] [Related]

  • 19. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z.
    Nature; 2002 Jun 27; 417(6892):941-4. PubMed ID: 12068310
    [Abstract] [Full Text] [Related]

  • 20. Comparison of RNAi NgR and NEP1-40 in Acting on Axonal Regeneration After Spinal Cord Injury in Rat Models.
    Xu J, He J, He H, Peng R, Xi J.
    Mol Neurobiol; 2017 Dec 27; 54(10):8321-8331. PubMed ID: 27921243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.